- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 127,900 | 01.07.24 22:00:44 | +4,100 | +3,31% | 127,820 | 128,030 | 129,540 | 123,800 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 84,850 | 01.07.24 22:00:08 | +0,590 | +0,70% | 82,570 | 87,060 | 83,760 | 84,260 |
